rs753556936
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP3BP6BS1BS2
The NM_001099922.3(ALG13):āc.880C>Gā(p.Pro294Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00000914 in 1,202,944 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P294S) has been classified as Likely benign.
Frequency
Consequence
NM_001099922.3 missense
Scores
Clinical Significance
Conservation
Publications
- genetic developmental and epileptic encephalopathyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 36Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- non-syndromic X-linked intellectual disabilityInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111866Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000404 AC: 7AN: 173246 AF XY: 0.0000488 show subpopulations
GnomAD4 exome AF: 0.00000825 AC: 9AN: 1091078Hom.: 0 Cov.: 28 AF XY: 0.0000168 AC XY: 6AN XY: 357022 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111866Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34102 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.P294A variant (also known as c.880C>G), located in coding exon 6 of the ALG13 gene, results from a C to G substitution at nucleotide position 880. The proline at codon 294 is replaced by alanine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Developmental and epileptic encephalopathy, 36 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at